The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT

被引：15

作者：

Kutscher S. ^{[1
]}

Dembek C.J. ^{[1
]}

Allgayer S. ^{[2
,3
]}

Heltai S. ^{[4
,5
]}

Stadlbauer B. ^{[2
,8
]}

Biswas P. ^{[6
]}

Nozza S. ^{[7
]}

Tambussi G. ^{[7
]}

Bogner J.R. ^{[9
]}

Stellbrink H.J. ^{[10
]}

Goebel F.D. ^{[9
]}

Lusso P. ^{[4
]}

Tinelli M. ^{[11
]}

Poli G. ^{[5
,12
]}

Erfle V. ^{[1
,2
]}

Pohla H. ^{[2
,8
]}

Malnati M. ^{[4
]}

Cosma A. ^{[1
,2
]}

机构：

[1] Institute of Virology, Helmholtz Zentrum München, German Research Center for Environmental Health

[2] Clinical cooperation group Immune monitoring, Helmholtz Zentrum München, German Research Center for Environmental Health

[3] Institute of Virology, Technical University

[4] Human Virology Unit, San Raffaele Scientific Institute

[5] AIDS Immunopathogenesis Unit, San Raffaele Scientific Institute

[6] Laboratory of Clinical Immunology, San Raffaele Scientific Institute

[7] Department of Infectious Diseases, San Raffaele Scientific Institute

[8] Laboratory for Tumor Immunoloy, LIFE-Zentrum, Ludwig-Maximilians-Universität München

[9] Department of Infectious Diseases, Med. Poliklinik, University Hospital of Munich

[10] IPM Study Center

[11] Division of Infectious and Tropical Diseases, Hospital of Lodi

[12] Vita-Salute San Raffaele University, School of Medicine

来源：

AIDS Research and Therapy | / 5卷 / 1期

关键词：

ELISPOT Assay; Specific Immune Response; Vaccine Trial; Wilcoxon Match Pair Test; Intracellular Cytokine Staining;

D O I：

10.1186/1742-6405-5-22

中图分类号：

学科分类号：

摘要：

Background: T-cell mediated immunity likely plays an important role in controlling HIV-1 infection and progression to AIDS. Several candidate vaccines against HIV-1 aim at stimulating cellular immune responses, either alone or together with the induction of neutralizing antibodies, and assays able to measure CD8 and CD4 T-cell responses need to be implemented. At present, the IFN-γ-based ELISPOT assay is considered the gold standard and it is broadly preferred as primary assay for detection of antigen-specific T-cell responses in vaccine trials. However, in spite of its high sensitivity, the measurement of the sole IFN-γ production provides limited information on the quality of the immune response. On the other hand, the introduction of polychromatic flow-cytometry-based assays such as the intracellular cytokine staining (ICS) strongly improved the capacity to detect several markers on a single cell level. Results: The cumulative analysis of 275 samples from 31 different HIV-1 infected individuals using an ICS staining procedure optimized by our laboratories revealed that, following antigenic stimulation, IFN-γ producing T-cells were also producing MIP-1β whereas T-cells characterized by the sole production of IFN-γ were rare. Since the analysis of the combination of two functions decreases the background and the measurement of the IFN-γ+ MIP-1β+ T-cells was equivalent to the measurement of the total IFN-γ+ T-cells, we adopted the IFN-γ+ MIP-1β+ data analysis system to evaluate IFN-γ-based, antigen-specific T-cell responses. Comparison of our ICS assay with ELISPOT assays performed in two different experienced laboratories demonstrated that the IFN-γ+ MIP-1β+ data analysis system increased the sensitivity of the ICS up to levels comparable to the sensitivity of the ELISPOT assay. Conclusion: The IFN-γ+ MIP-1β+ data evaluation system provides a clear advantage for the detection of low magnitude HIV-1-specific responses. These results are important to guide the choice for suitable highly sensitive immune assays and to build reagent panels able to accurately characterize the phenotype and function of responding T-cells. More importantly, the ICS assay can be used as primary assay to evaluate HIV-1-specific responses without losing sensitivity in comparison to the ELISPOT assay. © 2008 Kutscher et al; licensee BioMed Central Ltd.

引用

共 34 条

[1] Hanke T., McMichael A.J., Dorrell L., Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction, J Gen Virol, 88, pp. 1-12, (2007)
[2] Gudmundsdotter L., Sjodin A., Bostrom A.C., Hejdeman B., Theve-Palm R., Alaeus A., Lidman K., Wahren B., Therapeutic immunization for HIV, Springer Semin Immunopathol, 28, pp. 221-230, (2006)
[3] Yang O.O., Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes, Aids, 22, pp. 325-331, (2008)
[4] Russell N.D., Hudgens M.G., Ha R., Havenar-Daughton C., McElrath M.J., Moving to human immunodeficiency virus type 1 vaccine efficacy trials: Defining T cell responses as potential correlates of immunity, J Infect Dis, 187, pp. 226-242, (2003)
[5] Janetzki S., Schaed S., Blachere N.E., Ben-Porat L., Houghton A.N., Panageas K.S., Evaluation of Elispot assays: Influence of method and operator on variability of results, J Immunol Methods, 291, pp. 175-183, (2004)
[6] Samri A., Durier C., Urrutia A., Sanchez I., Gahery-Segard H., Imbart S., Sinet M., Tartour E., Aboulker J.P., Autran B., Venet A., Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay, Clin Vaccine Immunol, 13, pp. 684-697, (2006)
[7] Gudmundsdotter L., Bernasconi D., Hejdeman B., Sandstrom E., Alaeus A., Lidman K., Ensoli B., Wahren B., Butto S., Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles, Vaccine, 26, 40, pp. 5182-5187, (2008)
[8] Tassignon J., Burny W., Dahmani S., Zhou L., Stordeur P., Byl B., De Groote D., Monitoring of cellular responses after vaccination against tetanus toxoid: Comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, flow cytometry and real-time PCR, J Immunol Methods, 305, pp. 188-198, (2005)
[9] Tobery T.W., Dubey S.A., Anderson K., Freed D.C., Cox K.S., Lin J., Prokop M.T., Sykes K.J., Mogg R., Mehrotra D.V., Fu T.M., Casimiro D.R., Shiver J.W., A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjects, AIDS Res Hum Retroviruses, 22, pp. 1081-1090, (2006)
[10] Karlsson A.C., Martin J.N., Younger S.R., Bredt B.M., Epling L., Ronquillo R., Varma A., Deeks S.G., McCune J.M., Nixon D.F., Sinclair E., Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells, J Immunol Methods, 283, pp. 141-153, (2003)

← 1 2 3 4 →